Biocon receives US FDA approval for Liraglutide Injection gSaxenda EP News Bureau Feb 25, 2026 Approval covers 18 mg/3 mL prefilled pens for chronic weight management in the United States
Lupin gains US FDA approvals for Liraglutide and Glucagon Injectable Products EP News Bureau Jul 24, 2025 Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
